391 related articles for article (PubMed ID: 32724223)
1. The B cell immunobiology that underlies CNS autoantibody-mediated diseases.
Sun B; Ramberger M; O'Connor KC; Bashford-Rogers RJM; Irani SR
Nat Rev Neurol; 2020 Sep; 16(9):481-492. PubMed ID: 32724223
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies Targeting Intracellular and Extracellular Proteins in Autoimmunity.
Burbelo PD; Iadarola MJ; Keller JM; Warner BM
Front Immunol; 2021; 12():548469. PubMed ID: 33763057
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody-mediated disorders of the central nervous system.
Irani S; Lang B
Autoimmunity; 2008 Feb; 41(1):55-65. PubMed ID: 18176865
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive autoantigen-ome of autoimmune liver diseases identified from dermatan sulfate affinity enrichment of liver tissue proteins.
Zhang W; Rho JH; Roehrl MH; Wang JY
BMC Immunol; 2019 Jun; 20(1):21. PubMed ID: 31242852
[TBL] [Abstract][Full Text] [Related]
5. Blockade of autoantibody-initiated tissue damage by using recombinant fab antibody fragments against pathogenic autoantigen.
Wang G; Ujiie H; Shibaki A; Nishie W; Tateishi Y; Kikuchi K; Li Q; McMillan JR; Morioka H; Sawamura D; Nakamura H; Shimizu H
Am J Pathol; 2010 Feb; 176(2):914-25. PubMed ID: 20042683
[TBL] [Abstract][Full Text] [Related]
6. Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies.
Meffre E; O'Connor KC
Immunol Rev; 2019 Nov; 292(1):90-101. PubMed ID: 31721234
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity.
Suurmond J; Diamond B
J Clin Invest; 2015 Jun; 125(6):2194-202. PubMed ID: 25938780
[TBL] [Abstract][Full Text] [Related]
8. Glutamate Receptor Antibodies in Autoimmune Central Nervous System Disease: Basic Mechanisms, Clinical Features, and Antibody Detection.
Scotton WJ; Karim A; Jacob S
Methods Mol Biol; 2019; 1941():225-255. PubMed ID: 30707437
[TBL] [Abstract][Full Text] [Related]
9. High-Throughput Detection of Autoantigen-Specific B Cells Among Distinct Functional Subsets in Autoimmune Donors.
Joosse BA; Jackson JH; Cisneros A; Santhin AB; Smith SA; Moore DJ; Crofford LJ; Wilfong EM; Bonami RH
Front Immunol; 2021; 12():685718. PubMed ID: 34234784
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-33 Contributes Toward Loss of Tolerance by Promoting B-Cell-Activating Factor of the Tumor-Necrosis-Factor Family (BAFF)-Dependent Autoantibody Production.
Rose WA; Okragly AJ; Hu NN; Daniels MR; Martin AP; Koh YT; Kikly K; Benschop RJ
Front Immunol; 2018; 9():2871. PubMed ID: 30574145
[TBL] [Abstract][Full Text] [Related]
11. The long and the short of it: insights into the cellular source of autoantibodies as revealed by B cell depletion therapy.
Hale M; Rawlings DJ; Jackson SW
Curr Opin Immunol; 2018 Dec; 55():81-88. PubMed ID: 30390507
[TBL] [Abstract][Full Text] [Related]
12. Targeting B cells and autoantibodies in the therapy of autoimmune diseases.
Kao D; Lux A; Schwab I; Nimmerjahn F
Semin Immunopathol; 2014 May; 36(3):289-99. PubMed ID: 24777745
[TBL] [Abstract][Full Text] [Related]
13. Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system.
Sinmaz N; Nguyen T; Tea F; Dale RC; Brilot F
J Neuroinflammation; 2016 Aug; 13(1):219. PubMed ID: 27577085
[TBL] [Abstract][Full Text] [Related]
14. La/SSB chimeric autoantibody receptor modified NK92MI cells for targeted therapy of autoimmune disease.
Meng H; Sun X; Song Y; Zou J; An G; Jin Z; Yang L
Clin Immunol; 2018 Jul; 192():40-49. PubMed ID: 29673902
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease.
Flach AC; Litke T; Strauss J; Haberl M; Gómez CC; Reindl M; Saiz A; Fehling HJ; Wienands J; Odoardi F; Lühder F; Flügel A
Proc Natl Acad Sci U S A; 2016 Mar; 113(12):3323-8. PubMed ID: 26957602
[TBL] [Abstract][Full Text] [Related]
16. Autoantigen microarrays for multiplex characterization of autoantibody responses.
Robinson WH; DiGennaro C; Hueber W; Haab BB; Kamachi M; Dean EJ; Fournel S; Fong D; Genovese MC; de Vegvar HE; Skriner K; Hirschberg DL; Morris RI; Muller S; Pruijn GJ; van Venrooij WJ; Smolen JS; Brown PO; Steinman L; Utz PJ
Nat Med; 2002 Mar; 8(3):295-301. PubMed ID: 11875502
[TBL] [Abstract][Full Text] [Related]
17. Non-immunoglobulin serum proteins prevent the binding of IgG from normal rats and from rats with Th2-mediated autoimmune glomerulonephritis to various autoantigens including glomerular antigens.
Druet E; Praddaude F; Druet P; Dietrich G
Eur J Immunol; 1998 Jan; 28(1):183-92. PubMed ID: 9485198
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 35-Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases.
Egwuagu CE; Yu CR
Crit Rev Immunol; 2015; 35(1):49-57. PubMed ID: 25746047
[TBL] [Abstract][Full Text] [Related]
19. B Cell Modulation Strategies in Autoimmune Diseases: New Concepts.
Musette P; Bouaziz JD
Front Immunol; 2018; 9():622. PubMed ID: 29706952
[TBL] [Abstract][Full Text] [Related]
20. The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease.
Sim KY; Im KC; Park SG
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
